Tapering antidepressants requires careful planning to minimize withdrawal symptoms and ensure patient safety. This episode provides pharmacists with a brief update on antidepressant therapies and essential education on tapering, including recognizing withdrawal risks, adjusting schedules, and counseling patients effectively. Don’t miss this opportunity to stay informed and enhance your skills in supporting patients through their mental health treatment journey.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Sara Grady, PharmD, BCPS, BCPP
Professor, Clinical Pharmacist
Drake University
Broadlawns Medical Center

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanisms of action of antidepressant therapies and their implications for patient care.
2. Explain best practices for tapering antidepressants, including recognizing withdrawal risks and providing effective patient counseling.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-075-H01-P
Initial release date: 3/24/2025
Expiration date: 3/24/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

GLP-1 receptor agonists are revolutionizing healthcare, offering benefits far beyond glucose management—from weight loss to potential improvements in sleep apnea and cardiovascular health. This episode explores the multifaceted roles of GLP-1s, the latest evidence behind their expanding uses, and what pharmacists need to know to maximize their impact. Don’t miss this chance to stay informed on one of the most versatile classes of medications shaping patient care today!

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
John Swegle, PharmD
Clinical Associate Professor
University of Iowa College of Pharmacy

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the diverse therapeutic applications of GLP-1 receptor agonists, including their roles in glucose management, weight loss, and other emerging uses.
2. Identify key considerations for pharmacists in optimizing GLP-1 therapy to improve patient outcomes across various conditions.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-074-H01-P
Initial release date: 3/17/2025
Expiration date: 3/17/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Hypertension remains a leading contributor to cardiovascular disease, but advancements in its management are reshaping treatment strategies. This episode highlights the latest updates in hypertension guidelines, emerging therapies, and practical approaches pharmacists can use to optimize care. Don’t miss this chance to stay informed and elevate your role in improving patient outcomes.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Joseph Saseen, PharmD, BCPS, BCACP, CLS, ASH-CHC
Professor and Associate Dean for Clinical Affairs
University of Colorado
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent updates in hypertension management guidelines and their implications for patient care.
2. Identify emerging therapies and evidence-based strategies pharmacists can use to optimize hypertension treatment and improve outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-058-H01-P
Initial release date: 3/10/2025
Expiration date: 3/10/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Antibiotic resistance is a growing global crisis, and pharmacists are on the frontlines of combating this threat through effective stewardship practices. This episode explores the latest updates in antimicrobial stewardship and shares actionable strategies to combat resistance and optimize antibiotic use. Tune in to strengthen your role as a steward of antibiotic efficacy and help preserve these life-saving medications for future generations.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Geoff Wall, PharmD, FCCP, BCPS
Professor of Pharmacy Practice
Iowa Methodist Medical Center

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the impact of antibiotic resistance on public health and the role of antimicrobial stewardship in addressing this crisis.
2. Identify evidence-based strategies pharmacists can implement to optimize antibiotic use and combat resistance in their practice settings.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-057-H01-P
Initial release date: 3/3/2025
Expiration date: 3/3/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Alzheimer’s Disease remains one of the most pressing challenges in healthcare, with new treatments and research breakthroughs reshaping the landscape of care. This episode dives into the latest advancements, including current medications, clinical trials, and emerging therapies that pharmacists need to know. Stay informed and ready to support patients and caregivers—tune in to expand your expertise and navigate this evolving field with confidence.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
James Hoehns, PharmD, BCPS
Clinical Professor
University of Iowa

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the current treatment options for Alzheimer's Disease.
2. Identify key considerations for pharmacists when counseling patients and caregivers on Alzheimer's Disease management and emerging therapies.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-042-H01-P
Initial release date: 2/24/2025
Expiration date: 2/24/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Stay up-to-date on the latest advancements in antipsychotic medications and how they’re shaping the management of mental health conditions. This episode highlights new formulations, expanded indications, and emerging treatment trends that every pharmacist should know. Don’t miss the chance to enhance your expertise and improve patient care!

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Katelynn Mayberry, PharmD
Clinical Assistant Professor of Pharmacy Practice
Mercer University College of Pharmacy

REFERENCE
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.177901

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recall recent advancements in antipsychotic medications, including new formulations and expanded therapeutic indications.
2. Identify key considerations for pharmacists in optimizing the use of updated antipsychotic treatments to improve patient outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-031-H01-P
Initial release date: 2/17/2025
Expiration date: 2/17/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Explore the ADA 2025 Diabetes Guideline updates from a different lens – one focused on non-glycemic parameters like cardiovascular health, kidney protection, and weight management. This episode highlights evidence-based recommendations to equip pharmacists with the necessary knowledge to take a more holistic approach to patient care. Listen and discover how to integrate these key updates into your practice to improve outcomes beyond glycemic control.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Justinne Guyton, PharmD, BCACP
Associate Professor of Pharmacy Practice
University of Health Sciences and Pharmacy 

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify three key non-glycemic updates in the ADA 2025 Diabetes Guidelines.
2. Explain the pharmacists role in addressing non-glycemic parameters in diabetes care.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-030-H01-P
Initial release date: 2/10/2025
Expiration date: 2/10/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Learn the essentials of 340B pharmacy and how this program supports access to affordable medications for underserved communities. This episode simplifies key concepts, explains how 340B works, and offers practical guidance for pharmacists just getting started. Tune in to build your confidence and take the first step toward understanding the impact of 340B in your practice!

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Amanda Gaddy, R.Ph.
Co-Founder, COO
Secure340B

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the purpose and structure of the 340B Drug Pricing Program, including its role in expanding access to affordable medications.
2. Identify key responsibilities and considerations for pharmacists participating in 340B programs, including compliance and operational basics.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-020-H04-P
Initial release date: 2/3/2025
Expiration date: 2/3/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Are your student pharmacists or residents struggling with written communication? Join us for a candid conversation with experienced preceptor and former residency director Josh Kinsey, who shares creative, practical strategies to help pharmacy learners enhance their writing—from grammar and spelling to professional documentation and literature analysis. Discover tools, activities, and tips to foster these critical skills while balancing the demands of busy rotations. Tune in and gain insights that will empower you and your learners to succeed!
 
HOST
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

GUEST
Joshua David Kinsey, PharmD
Vice President, Education
CEimpact

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
 
Learning Objectives
At the end of this course, preceptors will be able to:
1. Identify common barriers that hinder student pharmacists writing development
2. Describe innovative and structured approaches to teach foundational and professional writing skills as part of experiential learning

0.075 CEU/0.75 Hr
UAN: 0107-0000-25-044-H99-P
Initial release date: 1/29/2025
Expiration date: 1/29/2028
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Stay ahead in stroke prevention with insights from the updated AHA/ASA guidelines, designed to optimize care for at-risk patients. This episode highlights key changes, actionable strategies, and the pharmacist’s role in reducing stroke incidence through evidence-based interventions. Tune in to stay informed and enhance patient outcomes in stroke prevention.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Justinne Guyton, PharmD, BCACP
Associate Professor of Pharmacy Practice
University of Health Sciences and Pharmacy

Reference
2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association
https://www.ahajournals.org/doi/10.1161/STR.0000000000000475

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify three key updates in the AHA/ASA 2024 Stroke Prevention Guideline.
2. Explain the pharmacists role in applying evidence-based strategies for stroke prevention.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-022-H01-P
Initial release date: 1/27/2025
Expiration date: 1/27/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram